The precise control of motor neuron (MN) death and survival following initial innervation of skeletal muscle targets is a key step in sculpting a functional motor system, but how this is regulated at the level of individual motor pools remains unclear. Hepatocyte growth factor (HGF) and its receptor Met play key developmental roles in both muscle and MNs. We generated mice (termed "Nes-Met") in which met is inactivated from midembryonic stages onward in the CNS only. Adult animals showed motor behavioral defects suggestive of impaired innervation of pectoral muscles. Correspondingly, in neonatal spinal cords of Nes-Met mutants, we observed death of a discrete population of pea3-expressing MNs at brachial levels. Axonal tracing using pea3 reporter mice revealed a novel target muscle of pea3-expressing MNs: the pectoralis minor muscle. In Nes-Met mice, the pectoralis minor pool initially innervated its target muscle, but required HGF/Met for survival, hence for proper maintenance of muscle innervation. In contrast, HGF/Met was dispensable for the survival of neighboring Met-expressing MN pools, despite its earlier functions for their specification and axon growth. Our results demonstrate the exquisite degree to which outcomes of signaling by receptor tyrosine kinases are regulated on a cell-by-cell basis. They also provide a model for one way in which the multiplicity of neurotrophic factors may allow for regulation of MN numbers in a pool-specific manner.
Introduction
Despite their shared overall function, neuronal classes comprise distinct subtypes, each of which reflecting functional characteristics, including anatomical position, molecular identity, and specific connectivity. How each subpopulation is generated during development at the correct time and place, and how appropriate numbers are maintained, are therefore critical issues for understanding neural development.
As an example of functional diversity, spinal motor neurons (MNs) are organized into discrete longitudinal columns that segregate spatially into motor pools, the groups of MNs that innervate individual skeletal muscles (Landmesser, 1978; Jessell, 2000) . Motor pools differ in MN numbers they contain, which reflect the volume of the target muscle and the number of muscle fibers innervated by each MN. Differences in final pool size are influenced by the initial MN number generated and by the fraction lost through subsequent developmental cell death. This adjustment of MN numbers within pools to the size of target musclesnumerical matching-involves the loss of a fraction of the MNs initially produced, during a specific developmental phase called naturally occurring cell death (NOCD) period, which peaks around E13.5 in mouse. This peak of cell death coincides with the moment when MNs become dependent on muscle-derived factors for survival, as deduced from the timing of MN elimination in mice with impaired muscle development ( Fig. 1) (Kablar and Rudnicki, 1999) . While some mechanistic origins of differences in initial MN numbers are known (Dasen and Jessell, 2009; Kanning et al., 2010) , evidence for pool-specific regulation of MN survival is still lacking, despite the plethora of factors exerting trophic support on cultured MN subsets (Henderson, 1996; Oppenheim, 1996) .
In this study, we focused on HGF and its receptor Met, which play complex developmental roles in the neuromuscular system (Maina and Klein, 1999) . HGF elicits survival response on MN subsets in vitro, and Met is selectively expressed in distinct motor pools ( Fig. 1) (Ebens et al., 1996; Yamamoto et al., 1997; Helmbacher et al., 2003) . Moreover, anti-HGF blocking antibodies abolish a muscle-derived neurotrophic activity. Several functions of HGF/Met additionally impact on MN biology: at early developmental stages, HGF is required for myoblast migration from somites to limbs (Bladt et al., 1995; Maina et al., 1996) . In hgf or met null mutants, absence of limb muscles results in trophic support depletion, hence causing death of all limbinnervating MNs ( Fig. 1) (Helmbacher et al., 2003) . Besides, HGF/Met control early MN specification by regulating expression of the pea3 transcription factor, and subtype-specific motor axon growth (Ebens et al., 1996; Maina et al., 1997 Maina et al., , 2001 Caton et al., 2000; Helmbacher et al., 2003) .
The subtype-specific action of HGF/Met led us to use this system for exploring in vivo whether MN subgroups depend on distinct trophic support, by combining two novel transgenic lines with four previously described mutants. We demonstrate that an individual motor pool requires a specific neurotrophic factor for its survival, and show that MNs switch their dependency for a given trophic factor in time and for defined biological functions in a pool-specific manner.
Materials and Methods

Animals and genotype analysis
All experimental procedures were performed according to the European Union and institutional guidelines for the care and use of laboratory animals, and were approved by an official committee. Mice were housed under a 12 h light/dark cycle, with dry food and water available ad libitum. For behavioral studies, we used adult (2-3 months old) male transgenic mice. The NesMet mutants were obtained through a genetic setting combining a conditional met allele [met fl (Huh et al., 2004) ], a signaling-deficient met allele [met d (Maina et al., 1996 (Maina et al., , 1998 ], and a strain in which Cre recombinase expression is driven by the nervous system-specific enhancer of nestin (Tronche et al., 1999) . To generate the Met LacZ/ϩ mice, a loxP-flanked-neostop cassette has been inserted into exon 12 of the met locus, resulting in a loss of function of the met gene. An IRES-nls-LacZ-pA targeting cassette was integrated into exon 12, so that expression of the ␤-gal reporter is conditioned by the excision of a neo-stop cassette. The targeting vector was electroporated into P1 ES cell lines (Institut Clinique de la Souris). Cell recombinants were screened with an external probe on SacI-digested genomic DNA. Oligonucleotides used for PCR screening were as follows: 5Ј-CAAGCCGAATCACCAAACACTAAGG-3Ј (oligo 1), 5Ј-CCAAGCTGATCCTCTAGAGT-CGAC-3Ј (oligo 2), 5Ј-CATCAGAAGCTGACT-CTAGAGG-3Ј (oligo 3), and 5Ј-GAATAGT CATGACGTCATCAGC-3Ј (oligo 4).
The Etv4-GFP BAC transgenic line was constructed in the research facility of Xenogen Biosciences. Construction began by isolation of the BAC RP24-79P16 (obtained from BACPAC Resources Center, CHORI), containing the murine Etv4 locus and its putative regulatory environment. The BAC-recombineering technology was used to originate a transgenic BAC, in which an EGFP cassette was inserted into the Etv4 locus of the BAC (Gong et al., 2002) . The EGFP shuttle cassette was designed to generate an in-frame fusion of the EGFP with exon 9 of Etv4, leading to a Etv4-GFP fusion transcript, and to replace exons 10 -13 of Etv4 in the BAC, such that the Etv4 locus is knocked out [strategy similar to that applied for Etv4 knock-out by (Livet et al., 2002) ] and does not lead to exogenous expression of a functional PEA3 protein. Pronuclear injections of the BAC transgene was performed in the B6SJL (hybrid) mouse strain, and 14 transgenic founder mice were obtained. The basis for selecting one transgenic founder from which to expand the Etv4-EGFP mouse line included a screening of the progeny of each transgenic founder for EGFP reporter expression at embryonic stages E12.5 or E13.5. The selected line (founder male number 4) shows an EGFP staining pattern that recapitulates pea3 expression in the spinal cord and in other tissues, and is detectable in direct fluorescence. The official international name to be used is Tg(Etv4-EGFP)4Hel. Transgenic mice are identified by genomic PCR with the following primers: pea3-a1 5Ј-GGAATCTTGGGCCTTGAGAACAGC-3Ј; GFP-rev 5Ј-CGCTGAAC-TTGTGGCCGTTTACG-3Ј. Other mouse lines used in this study were Del-Ret and Nes-Ret (Kramer et al., 2006) . Mice carrying the runx1 LacZ allele were obtained from Marella de Bruijn (John Radcliffe Hospital, Oxford, UK), with permission of Nancy A. Speck (University of Pennsylvania, Philadelphia, PA) and genotyped as described by North et al. (1999) . Mice carrying the pea3 null allele (Etv4 tm1Arbr allele) were obtained from Silvia Arber, and genotyped as previously described (Livet et al., 2002) .
Embryonic MN cultures
E12.5 mouse embryos were collected in Hibernate medium (Invitrogen) with B-27 supplement (Invitrogen), and kept on ice until dissection, while the genotype was determined by PCR. Ventral spinal cords from an equal number of wild-type and met d/d mutant embryos were dissected. mutants where limb muscle development is impaired. The scheme also summarizes the different developmental events regulated by HGF/Met functions in MNs (based on Helmbacher et al., 2003) . Before NOCD, HGF/Met is required for axonal growth, for induction of Runx1 expression in Met-positive neurons (cell autonomously), and for the propagation of Pea3 expression from Met-positive to Met-negative MNs (non-cell-autonomous function). After NOCD (E15.5), depletion of limb muscles in met d/d mutants causes the massive loss of all limb innervating MNs (whether they express Met or not). This had prevented so far using the HGF/Met system to study subtype-specific MN survival in response to selective trophic support. This question is the aim of the present study (blue arrow).
MNs were isolated either from brachial ϩ lumbar or from cervical ϩ thoracic ϩ sacral segments, by a previously described method (Arce et al., 1999) , involving a combination of BSA cushion centrifugations and a metrizamide density gradient centrifugation. At the end of the procedure, the cell suspension is highly enriched in MNs. Cells were then plated in polyornithine/laminin-coated four-well tissue culture dishes for survival experiments (1500 neurons per well) in Neurobasal medium. Recombinant neurotrophic factors were added 2 h after seeding. MNs were kept for 3 d either in Neurobasal medium or in the presence of GDNF or HGF (both obtained from R&D). MN survival was quantified by counting large, bright unipolar neurons with long axonal processes on the whole area of each well.
In situ hybridization and quantification of MN numbers
In situ hybridization on whole-mount embryos were performed as previously described (Maina et al., 1996 (Maina et al., , 2001 . Spinal cords were dissected at the appropriate stage, with long spinal roots, allowing unambiguous identification of every spinal segment, and fixed overnight in 4% PFA. Fragments of spinal cords including the C5-T2 segments were frozen in PBS, 20% sucrose, and 7.5% gelatin, and cryosectioned (16 m) transversally. In situ hybridization studies on whole-mount spinal cords or cryosections were performed as previously described (Helmbacher et al., 2003) . Riboprobes used in this study were for met (Yamamoto et al., 1997) , pea3 (from T. Jessell, Columbia University, New York, NY), sema3E (from J. Livet, The Vision Institute, Paris, France), runx1 (clone IRAKp961C01148Q, ImaGenes), and choline acetyltransferase (ChAt) (from C. Henderson, Columbia University, Motor Neuron Center, New York, NY). Quantitative analysis was performed by counting the number of ChAt-, pea3-, or runx1-positive MNs on one of every four sections throughout the entire length of the C5-T2 region. Presence or absence of dorsal roots allowed us to determine precisely the anteroposterior coordinates of each section. For each mice group, each side of the spinal cord sections was counted separately.
␤-Galactosidase staining
X-gal staining was performed according to standard techniques on whole embryos or dissected spinal cords. For Met LacZ/ϩ or runx1 LacZ/ϩ motor neuron counts, dissected spinal cords were fixed 2 h in 4% PFA and C5-T2 spinal segments were then embedded in gelatin/albumin. Fiftymicrometer-thick vibratome serial cross sections were collected and subjected to X-gal staining. LacZ-positive MNs were counted on all sections. For each genotype, left and right sides of the spinal cord sections were counted separately. As described for the in situ hybridization, the anteroposterior coordinates of each section was determined thanks to the presence of the spinal segments.
Immunohistochemistry
Immunostaining of embryos were performed as previously described (Maina et al., 2001) . Whole-mount immunohistochemistry on muscles was done as described previously (Livet et al., 2002) . Antibodies and reagents used were as follows: anti-neurofilament (␣-NF-M, 1:400), anti-Tau (1:50), anti-GFP (1:500), peroxidase-conjugated anti-rabbit antibodies (1:200), Alexa 555-conjugated anti-rabbit (1:400), Alexa 488-conjugated anti-chicken (1:500), and Alexa 594-conjugated phalloidin (1:40). For whole-mount immunohistochemistry, pectoralis minor and pectoralis major muscles were dissected, fixed in Dent's solution overnight, and subjected to immunohistochemistry using anti-NF antibodies. Peroxidase activity of the secondary antibody was developed with DAB (Sigma). Each muscle was imaged in two stereotyped positions (clavicular and thoracic regions) at 10ϫ magnification. Two-dimensional scoring of axonal arborization was performed using the NeuronJ plugin (Meijering et al., 2004) to ImageJ software (NIH), by drawing axon branches following the observable pattern, and plotting separately the length and number of branches, with each dot representing data from individual muscle. For analysis of neuromuscular junctions (NMJs), dissected muscles were fixed in 4% PFA (20 min), cryoprotected in 15% sucrose overnight at 4°C, and then frozen in 15% sucrose/7.5% gelatin. Forty-micrometer-thick longitudinal cryostat sections were collected on glass slides. They were first stained for 1 h in Alexa 488-conjugated ␣-bungarotoxin (BTX, 1:1000), then washed in PBS/0.1% Triton, permeabilized in methanol for 5 min at Ϫ20°C, washed, and subjected to standard immunohistochemistry with anti-NF or anti-Tau antibodies (P2 or adult, respectively). NMJs were observed under a Zeiss Axioplan microscope equipped with Apotome, and classified as follows: "completely innervated": the end-plate totally overlapped with the axon terminal; "denervated": the end-plate was not associ- ated with an axon. In case of partial overlap, the NMJ was scored as "partially innervated." To perform imaging of the EGFP fluorescence in Etv4-GFP-derived material, tissues were shortly fixed in 4% PFA. Spinal cords were dissected from E12.5 embryos before 15 min fixation, while muscles were dissected from E12.5 or E17.5 embryos previously fixed for 15 or 30 min, respectively. All tissues were rinsed three times in PBS. Muscles were further incubated in PBS supplemented with Alexa 594-conjugated ␣-bungarotoxin (1:1000) for 30 min, and rinsed again three times in PBS, before direct imaging of the GFP fluorescence. Double immunofluorescence with anti-NF (red) and chicken-anti-GFP (green) were performed as described above on dissected pectoralis minor muscles. All samples were mounted on slides with Prolong Gold Antifade Kit (Invitrogen). Image acquisition was performed with a Zeiss Axioplan equipped with Apotome.
Antibodies and reagents
Antibodies used were anti-tubulin (Sigma), anti-mouse Met (B-2; sc-8057, Santa-Cruz), anti-neurofilament (rabbit anti-NF AB1987, Millipore, and mouse anti-NF155 kDa clone 2H3 from Developmental Studies Hybridoma Bank), anti-Tau (Ab8763, Abcam), chicken-anti-GFP (Aves Labs), anti-rabbit peroxidase-or Cy3-coupled secondary antibodies (Jackson ImmunoResearch Laboratories), and anti-chicken Alexa 488 and antirabbit Alexa 555-coupled secondary antibodies (Invitrogen). Other reagents were Alexa 488-or Alexa 594-conjugated ␣-bungarotoxin and Alexa 594-coupled phalloidin (Invitrogen).
Western immunoblotting
Protein extracts were prepared from freshly dissected spinal cords at the appropriate stages and Western-blot analyses were performed as previously described ( 
Behavioral tests
The behavioral tests used in this study aimed at measuring motor abilities of the conditional Nes-Met mutant mice. They allowed evaluating motor coordination (rotarod) and muscular strength (grip and wire hanging tests). All animals used for this study were 2-3 months old.
Rotarod test. The rotarod test, using an accelerating rotarod, was performed by placing mice on rotating drums (3 cm diameter) and measuring the time each animal was able to maintain its balance on the rod. The speed of the rotarod accelerated from 4 to 40 rpm over a 5 min period.
Grip test. The grip strength of each animal was measured using an isometric dynamometer connected to a grid (Bioseb). Each mouse was made to grasp the grid with its forepaws, and was slowly pulled back by the tail until release of the grid. The maximal strength developed was recorded and expressed in newtons. Five individual trials were performed for each mouse, and the average value was used for statistical analysis.
Wire hanging test. The apparatus was a wire stretched horizontally 40 cm above a table.
Testing consisted of three consecutive trials separated by 30 min interval. On each trial, the forepaws of the animal were placed on the thread. The latency the animal took to catch the wire by one of its hindpaws was recorded (60 s maximum). If the animal fell down, it was credited with 60 s.
Statistical analysis
All data are presented as mean Ϯ SEM. Data were analyzed with Student's t test. p values Ͼ0.05 were considered nonsignificant. *p Ͻ 0.05, **p Ͻ 0.01, ***p Ͻ 0.001.
Results
Subtype-specific regulation of spinal MN survival by HGF/Met
Given the plethora of factors with neurotrophic properties, and the combinatorial, pool-specific expression of their receptors, could one given target-derived factor be necessary and sufficient for the survival of a limited subset of MN pools? Although HGF is produced by most muscles (Gu and Kania, 2010) , the restricted expression of Met in subsets of MN pools may reflect their specific dependency on HGF/Met signaling for survival. HGF was previously reported to support primary embryonic MN survival in vitro (Ebens et al., 1996; Wong et al., 1997; Yamamoto et al., 1997; Novak et al., 2000; Koyama et al., 2003) , and in vivo in ALS animal models (Genestine et al., 2011) . However, the massive elimination of limb-innervating MNs resulting from migratory muscle depletion in Met mutants occurs whether or not MNs express Met. While this defined the onset of the muscledependent period ( Fig. 1) , it precluded so far using the HGF/Met system to obtain in vivo evidence of pool specific requirement to a given trophic signal.
To first obtain in vitro genetic evidence that Met is required for the survival response to HGF, we used primary mouse MN cultures derived from wild-type or met d/d signaling mutant embryos. The response to HGF was assessed for both limb-innervating (brachial ϩ lumbar; BϩL) and non-limb-innervating (anterior cervical ϩ thoracic ϩ sacral; CϩTϩS) segments. At either level, only a fraction of MNs survived in presence of HGF (Fig. 2 A) , likely reflecting the expression of Met by subsets of MNs in vivo.
In met d/d signaling mutants, the effect of HGF on cultured MNs was lost, as expected (Fig. 2 A) . Interestingly, as reported with rat MNs (Yamamoto et al., 1997) , the HGF concentrations required for efficient support of non-limb-innervating medial motor column neurons, in which Met is also expressed, are higher than those required for brachial and lumbar lateral motor column neurons (BϩL: 0.4 ng/ml; CϩTϩS: 10 ng/ml) (Fig. 2 B) (Yamamoto et al., 1997) , suggesting a greater dependence of limb-innervating MNs on HGF for their survival. Consistently, no excessive loss of MNs was observed in met d/d spinal cords outside lateral motor columns at E15.5 (just after the NOCD period), excluding any major requirement for HGF/Met for their survival, at least at this stage.
We therefore set out to characterize how Met expression among brachial MN subsets might be relevant for survival. As previously shown, in the brachial spinal cord at E12.5, met expression is restricted to some motor pools, including those located in the most posterior region of the pea3 domain (Fig. 2C ) (Helmbacher et al., 2003) . This expression is maintained at E15.5, after the peak of NOCD (Fig. 2C) (Yamamoto et al., 1997) . In addition to expression in medial/hypaxial motor columns at cervical and thoracic levels, high levels of met are detected in MNs corresponding to the posterior (C7-T1) part of the pea3 domain ( Fig. 2C) (Helmbacher et al., 2003) . Thus, a differential HGF response of MN subgroups combined with the restricted expression of met in subsets of lateral motor column pools in the brachial region suggested that MN pool might vary in their requirements for trophic support in vivo. 
Specific motor performance defects in adult conditional
Nes-Met mutants
To selectively inactivate Met signaling in the nervous system and bypass not only embryonic lethality, but also the muscle migration defect and consequent trophic depletion, we used combinations of three alleles: (1) a conditional met allele [met fl (Huh et al., 2004) ], (2) a functionally null met allele [met d (Maina et al., 1996) ], and (3) a strain in which Cre recombinase expression is driven by the nervous systemspecific enhancer of nestin (Tronche et al., 1999 (Fig. 3C) . In contrast, the wire hanging test, which involves recording the time the animal takes to lift up its trunk so that it can catch the wire by one of its hindpaws, revealed a clear functional defect in the Nes-Met fl/d mutants (Fig. 3D) . Notably, a number of Nes-Met fl/d mice were capable of holding the wire and eventually grasping it with their hindpaws, whereas others were not able to hang on the wire and were falling down, indicating a variability of the severity of the phenotype. The specific performance defects uncovered by the wire hanging test, but not the grip test, suggested defective innervation of some, but not all, forearm and/or pectoral muscle(s), indicating that only a subset of MNs might be affected.
MN specification and axon guidance are preserved in conditional
Nes-Met mutants Deciphering the specific dependence of brachial MN subgroups on HGF for survival required that a genetic system also preserves three early neuronal functions of Met. First, Met is required for axonal growth to the Pea3 target muscles cutaneous maximus and latissimus dorsi (Maina et al., 1997 (Maina et al., , 2001 ). Second, Met is required non-cell autonomously for ex- pansion of Pea3 expression, after its initial induction by GDNF ( Fig. 1) (Helmbacher et al., 2003) . Third, we found that Met (as well as Pea3) is also required for expression of the transcription factor Runx1 (Dasen et al., 2005; Stifani et al., 2008) in the caudal part of the Pea3 domain (C7-C8 levels), where Met is coexpressed (Fig. 2C,D) (Stifani et al., 2008) . Indeed, runx1 expression was lost at E12.5 in both pea3 Ϫ/ Ϫ and in the met signaling-deficient (met d/d ) mutants (Fig. 2 D) , while it was preserved in both mutants in other, more anterior, cervical motor pools. Runx1 expression distinguishes two subgroups of neurons coexpressing met and pea3: one runx1-positive at C7-C8 levels, and a second population runx1-negative, extending more caudally to T1 (Fig. 2C) . We reasoned that the Nes-Met fl/d mutants could be an appropriate genetic setting to preserve these early Met neuronal functions, as we observed a limited efficiency of the nestincre transgenic line on Ret deletion in the pea3-positive MN population by E12.5 (data not shown and Kramer et al., 2006) .
We therefore determined when Met protein expression was extinguished in Nes-Met fl/d spinal cords by Western blot analysis and found only slight reduction at E11.5 and E13.5 (Fig. 4 A and data not shown). By contrast, at E15.5, there was a stronger reduction in levels of Met protein in Nes-Met fl/d mutant spinal cords than in those of controls (Fig. 4 A) . Thus, this time course of Met protein depletion might allow preserving its early neural functions and investigating its contribution to MN survival after the peak of NOCD. To confirm this, we first examined expansion of the pea3 expression domain in Nes-Met fl/d mutants, which occurs between E10.5 and E12.5 (Helmbacher et al., 2003) . Whole-mount in situ hybridization showed normal expression of pea3 and of its target genes sema3E and runx1 (Fig. 4 B and data not shown). Moreover, there were indistinguishable numbers of pea3-positive MNs in E15.5 Nes-Met fl/d mutants and controls (Fig. 4C) . Second, the characteristic branching pattern of motor axons in the cutaneous maximus, a muscle target of the pea3-expressing MNs, was also preserved at E12.5, a stage at which it was totally absent in met d/d embryos (Fig. 4 D) . Overall, therefore, our conditional genetic model preserves both the non-neural and early neural functions of Met in the pea3 domain, namely expansion of pea3 pools, correct innervation of the pea3 target cutaneous maximus muscle, and induction of runx1 expression. Thus, the Nes-Met fl/d mice provide a unique tool for genetically exploring the role of Met in MNs after the NOCD period.
One caveat for interpretation of these data was that although we had shown that Met expression was maintained sufficiently at early stages, the degree of Met inactivation at later stages had not been followed on a cell-by-cell basis. To analyze met excision in the conditional null mutants, we needed a system to genetically label neurons in which Met is deleted, termed here as recombinedmet neurons. We therefore generated mice in which a loxP-stoploxP-lacZ cassette was introduced into the met locus (referred to as Met stop-LacZ/ϩ ). This created not only a loss-of-function allele of met, but also a conditional reporter of expression from the met locus ( Fig. 5A and data not shown), since LacZ reporter expression is only activated following cre-mediated excision of the floxed stop cassette. We first validated the Met stop-LacZ/ϩ reporter strain by crossing these mice with deleter-cre transgenics. We found that, in this context of ubiquitous Cre activity (mice are referred to as Del-Met LacZ/ϩ ), ␤-galactosidase staining recapitulated the expression pattern of met mRNA (Fig. 5B) . In the spinal cord, ␤-galactosidase staining at brachial, thoracic, lumbar, and sacral spinal cord levels faithfully reproduced the endogenous mRNA expression pattern in MN columns (Fig. 5C and data not shown) . The extent of Met deletion driven by the nestin-cre allele was followed by generating nestin-cre;met LacZ/ϩ animals (referred to as Nes-Met LacZ/ϩ ). At E15.5, Nes-Met LacZ/ϩ embryos displayed a pattern of ␤-galactosidase activity similar to that seen in DelMet LacZ/ϩ spinal cords and to the pattern of endogenous met mRNA expression (Fig. 5C) . Quantification of LacZ-expressing cell numbers on E15.5 Nes-Met LacZ/ϩ brachial spinal cord sections revealed that nestin-cre-mediated excision occurred in ϳ80% of MNs as compared to the germline deleter strain (C5-C7: 77%; C8 -T1: 81.2%; data not shown). These experiments therefore defined conditions for efficient met excision in the pea3 domain at stages after specification, axonal growth, and NOCD peak have occurred, allowing us to investigate for the first time the role of HGF/Met in later stages of MN development.
Fate of MNs following late inactivation of Met
Combining the met LacZ null allele with both the conditional met fl allele and nestin-cre (Nes-Met fl/LacZ ) inactivates met and allows the resulting recombined-met neurons within the met-expression domain to be visualized following X-Gal staining. Analysis of P2 brachial spinal cords revealed that a large proportion of recombined-met neurons could be detected in Nes-Met fl/LacZ spinal cords (Fig. 6A) . However, a detailed analysis of their anteroposterior distribution revealed a localized area, restricted to C8 -T1 levels, characterized by a ϳ50% reduction in the number of recombined-met neurons in Nes-Met fl/LacZ mutants compared to Nes-Met LacZ/ϩ controls (Fig. 6A,B) -therefore likely excluding the most rostral met-expressing MNs at C7 level. Moreover, the missing cells appeared to correspond to a group of MNs in a characteristic medioventral position, suggesting that they might correspond to one or more motor pools ( Fig. 6 A and data not shown) . In contrast, we found no significant reduction in the number of ␤-galactosidase-positive neurons at more anterior cervical levels or in any thoracic segments (Fig. 6 B and data not shown). Together, these findings suggested that between E15.5 and P2, after the peak of NOCD, a group of recombined-met neurons had been eliminated, and that Met signaling might be required for the survival of a specific MN population confined to the C8 -T1 region.
However, it remained necessary to confirm that the Met-positive cells missing in Nes-Met LacZ/fl spinal cords at P2 were indeed MNs, and to exclude the possibility that the reduction in lacZ-positive cell numbers was due to altered expression of the reporter gene. We therefore quantified MN numbers at different stages using in situ hybridization with a ChAT riboprobe. Similar MN numbers were observed in mutants and controls at E15.5 (data not shown), as expected. However, by P2, there was a significant reduction in Nes-Met fl/d (22.4 Ϯ 1.8% loss) and in Nes-Met fl/LacZ mutants (data not shown) as compared to controls (Fig.  7A-C) . As with LacZ-labeled neurons, the loss was limited to C8 -T1 levels (Fig. 7C) . In adult mice, no further reduction in MN number was observed (17.1 Ϯ 1.4% loss; data not shown). Thus, inactivation of met after the peak of NOCD triggers the loss of a subgroup of MNs in the C8 -T1 spinal cord segment.
MNs lost in the conditional Nes-Met mutants correspond to the most caudal subset in the brachial spinal cord
We next asked whether MNs lost in the conditional met mutants corresponded to a specific motor pool and whether they might exhibit a shared molecular identity. Given the known coexpression of met with pea3 in the caudal part of the pea3 expression domain, we confirmed at E15.5 and P2 that recombined-met neurons identified by ␤-galactosidase activity colocalize with pea3 (identified by in situ hybridization; data not shown). We therefore sought to determine whether the C8 -T1 neurons missing at P2 in Nes-Met fl/d mutants corresponded to subsets of pea3-positive MNs. Although the level of pea3 expression is maximal at developmental stages E11 to E16 and progressively diminishes, it is still possible to detect pea3 mRNA levels in MNs (as well as in small cells of glial appearance throughout the spinal cord) at P2. Quantification revealed a significant reduction in the number of pea3-positive MNs in the Nes-Met fl/d spinal cords, once again in the region comprising the end of C8 to T1 segments (Fig. 8 A-D,I ). This corresponds to the most posterior region of the pea3 domain, which did not match with the known anteroposterior extent of either the cutaneous maximus (C7-T1) or latissimus dorsi (C7) motor pools (Vrieseling and Arber, 2006) . Since the loss of MNs was quantitatively and spatially restricted, we asked whether they might correspond to a specific subset of those that normally express Met. To distinguish them among the pea3-expressing MNs and determine their identity with respect to the pool expressing runx1, we took advantage of a nls-LacZ insertion in the runx1 locus (Roth et al., 1999 LacZ/ϩ control mice (Fig. 8 E-H,J ) . Thus, the MNs whose survival is dependent on Met are distinguishable by their met ϩ ;pea3 ϩ ;runx1 Ϫ molecular identity and appear to correspond to the more caudal of the two Met-expressing groups defined in our expression study. Our findings are consistent with the idea that the Met-dependent MNs constitute a pool, which maps to the C8 -T1 level and projects to an as yet unidentified muscle. Given the small number of neurons that are lost in Met mutants, our prediction was that this was most likely a small muscle.
Reduced motor axon arborization in the pectoralis minor muscle of conditional Nes-Met mutants As a step toward identifying the muscle innervated by the Met-dependent motor pool, we next asked whether the loss of C8 -T1 MN group in Nes-Met fl/d mutants was accompanied by a defect in innervation of a specific muscle. We performed anti-neurofilament staining on muscles dissected from newborn Nes-Met fl/d and controls. Although the affected MN pool belongs to the pea3 domain (Livet et al., 2002; Helmbacher et al., 2003) , no significant alterations of the pattern of nerve terminals were found in the known pea3 target muscles cutaneous maximus or latissimus dorsi (data not shown), as expected from the unchanged numbers of runx1-positive MNs, and from the anteroposterior position of MNs innervating these muscles. Moreover, the innervation pattern of the pectoralis major, a pectoral muscle known to receive axonal projections from pea3-negative C7-C8 MNs, but to be indirectly influenced by defects in pea3 MNs (Vrieseling and Arber, 2006) , was also unaffected (data not shown).
The target muscle of the Met-dependent C8-T1 MNs should be innervated by axons from pea3-expressing MNs. Staining for ␤-galactosidase activity in pea3 tauLacZ reporter mice previously ruled out the presence of LacZ ϩ axons in the limb (Livet et al., 2002) . Because pea3 motor pools nevertheless belong to the lateral motor column, we focused on pectoral belt muscles, which receive lateral motor column innervation. We considered the pectoralis minor muscle, a small muscle not included in previous studies in mouse, as one candidate, presuming that its C8 -T1 innervation reported in human is conserved in mouse. Using anti-neurofilament staining on dissected pectoralis minor, we found a significant reduction in its axonal arborization profile in Nes-Met fl/d mutants compared to controls, as assessed by quantifying both the length and the number of branches of primary and second order (Fig. 9) . The reduced profile of axonal arborization, which provides an indication on the number of axons/MNs, suggests a reduced motor pool size in Nes-Met fl/d mutants. As such an innervation defect was not seen in other muscles, the loss is likely to be confined to one motor pool rather than distributed among several pools.
To determine whether the pectoralis minor is indeed innervated by pea3-expressing MNs, we generated a transgenic mouse in which the GFP reporter gene has been inserted into the pea3 locus in a large BAC encompassing the gene and the surrounding genome ( Fig. 10 A and data not shown) (since the official name of the pea3 locus is Etv4, we refer to the BAC-transgene as Etv4- EGFP to avoid confusion with the endogenous pea3 locus). The EGFP reporter in Etv4-EGFP mice fully recapitulates the pea3 expression domain in the spinal cord and in other known domains ( Fig. 10 and data not shown) . In the BAC transgene, the EGFP fusion was designed such that the EGFP-tag replaces the pea3 ETS domain, known to mediate DNA binding, and to be required for nuclear localization of Pea3 (Fig. 10A) (Janknecht, 1996; Janknecht et al., 1996) . Therefore, the Pea3-EGFP fusion protein produced by the BAC is not retained in the nucleus, allowing EGFP staining of the cytoplasm and axons (Fig. 10C-I and data not shown). Thus, the Etv4-EGFP transgenic provides an excellent tool to precisely map the target muscles of pea3 motor pools, refining the results obtained by retrograde tracing (Vrieseling and Arber, 2006) . As expected, we observed EGFPpositive axons in the cutaneous maximus, both at E12 and at E17.5 (Fig. 10 E-I and data not shown), as well as in the latissimus dorsi and some in the pectoralis major (data not shown). Overall examination of the EGFP signal in the pectoralis minor at E17.5 mostly revealed staining in tendons and muscle spindles, two previously reported sites of pea3 expression in muscles (Fig. 11) (Hippenmeyer et al., 2002; Brent and Tabin, 2004) . At higher magnification, however, EGFPpositive axons colocalized with anti-neurofilament staining (Fig. 11) . This result confirms that the pectoralis minor indeed receives axonal projections from pea3-expressing MNs.
We next determined the state of innervation of endplates of the pectoralis minor muscle at P2 and found an increased incidence of partially or completely denervated synapses in NesMet fl/d mutants as compared to controls (Fig. 12 A-D) . By contrast, no neuromuscular junction defects were observed in the pectoralis major of the Nes-Met fl/d mutants (Fig. 12 E) . Similar defects of endplate innervation were also found in adult mutants compared to control animals ( Finally, we asked whether the altered axonal profile found in P2/adult Nes-Met fl/d mutants is a consequence of deficient innervation of the pectoralis minor muscle (reflecting Met requirement at early stages) or truly resulted from degeneration of axons following neuronal loss. We therefore examined the innervation pattern of the pectoralis minor muscle at early developmental stages by performing whole-mount anti-neurofilament staining. Although a branching pattern within the pectoralis minor cannot unambiguously be identified in wild-type embryos at E12.5, dissection of the brachial plexus and removal of limb and limbinnervating nerve branches allows the lateral and medial pectoral nerve branches (lpn and mpn, respectively) (Fig. 4 D) to be recognized. The lpn and mpn emerge from the anterior and posterior parts of the plexus, respectively. Notably, we found that in contrast to cutaneous maximus axons, which are severely affected at E12.5, the mpn, which contains C8 -T1 axons projecting toward both the pectoralis minor and pectoralis major muscles, was unaffected at the same stage in both the conditional Nes-Met fl/d and the met d/d loss-of-function mutants (Fig. 4 D) , even though both muscles were reported to be missing in the latter mutants (Prunotto et al., 2004) . Furthermore, analysis of the pectoralis minor muscle at E15.5 revealed similar innervation pattern between Nes-Met fl/d and control embryos (Fig. 13) , in contrast to the innervation defects found after birth (Fig. 9A) .
Together, our findings indicate that Met is dispensable for initial axonal growth of MNs innervating the pectoralis minor muscle, in contrast to its known role in enhancing axonal growth of MNs innervating the latissimus dorsi and the cutaneous maximus (Ebens et al., 1996; Maina et al., 1997 Maina et al., , 2001 ). Instead, MNs in the pectoralis minor pool are dependent on HGF/Met for their survival during late embryogenesis, and after the peak of NOCD, in contrast to latissimus dorsi and cutaneous maximus MN pools that do not significantly require HGF/Met signaling for their survival (Fig. 14) . The reduction in number of the pectoralis minor pool in conditional Met mutants leads to denervation of the target muscle that appears sufficient to explain the specific weakness observed in the wire hanging test (Fig. 3) .
Discussion
Precise control of MN numbers on a pool-by-pool basis during development is likely a key step in building a functional motor system. Our data reveal that one neurotrophic factor is required for embryonic survival of a single motor pool in the brachial spinal cord. In the absence of neurotrophic support, these neurons-but not neighboring pools expressing the same receptor-undergo cell death, leading to functional deficits that are behaviorally significant. This demonstrates the exquisite degree to which outcomes of signaling by receptor tyrosine kinases are regulated on a cell-bycell basis. Moreover, our results provide a model for one way in which the multiplicity of neurotrophic factors may allow for regulation of MN numbers in a poolspecific manner.
Subtype specificity in the survival requirement of MNs: the HGF/Met example The cre-loxP-mediated conditional deletion of met in the nervous system used in this study (Nes-Met fl/d mutants) allowed us bypassing the early developmental requirements for Met and to reveal that, within a developmental window encompassing E15 to P2, a selective population of MNs strictly depends on Met for survival. We showed that Met is dispensable for the survival of MNs projecting to the cutaneous maximus and the latissimus dorsi. In contrast, MNs of the pectoralis minor pool require functional Met receptor for their survival after the peak of NOCD (Fig. 14) . As effective Met deletion in our genetic system occurs after E15.5, it remains to be established whether survival of the pectoralis minor pool depends on HGF, or on other trophic factor(s), during the peak of NOCD. These findings shed light on how a neurotrophic factor such as HGF acts on a subset of MNs and delineate the timeframe in which its trophic effects are exerted. However, they also raise intriguing questions about the mechanisms through which specificity is generated, and the requirements of MNs for trophic support at different stages of their maturation.
The specificity of HGF dependency for MN survival within the pea3 domain might potentially arise in the MNs themselves or from the target muscles. Previous studies followed the expression pattern of trophic factors in the target muscle and that of their Figure 10 . Generation of Etv4:EGFP mice and whole-mount imaging of EGFP-labeled axons and axon terminals in the cutaneous maximus. A, Schematic representation of the strategy used. The Etv4 locus is located on mouse chromosome 11. After fusion to the EGFP cassette (green), the resulting Etv4-EGFP fragment has been introduced into the BAC RP24 -79P16. Genomic organization of the Etv4 locus and localization of the site of insertion of the EGFP cassette (green), which has been inserted in frame with exon 9 of Etv4. The strategy also included the deletion of exons 10 -13 of Etv4 in the BAC, such that the Etv4 locus is knocked out and does not lead to expression of functional Etv4 (Pea3) protein. B-D, Histological analyses showing that EGFP expression reproduces the domain of pea3 expression. Analysis of whole-mount spinal cord of E12.5 Etv4-EGFP embryos. Comparison between in situ hybridization using a pea3 riboprobe (B) and direct observation of the GFP (C, D) reveals that the strong EGFP expression faithfully recapitulates that of pea3 transcripts. E, Low-magnification view of ramifications of bundles of fluorescent axons in the CM. F, High-magnification imaging shows that each bundle is composed of many individual axons. G-I, ␣-Bungarotoxin staining of the NMJs (BTX, red) in combination with Etv4-EGFP labeling (green) of motor axon terminals reveal clusters of synapses innervated "en passant" by single axons (G, H 1 -H 3 ) . I 1 -I 3 , The PEA3-GFP fusion protein reaches and fills axon terminals, fully overlapping with the BTX-labeled (red) Acetylcholine receptor clusters.
corresponding receptors in MNs (Gould and Oppenheim, 2004; Gu and Kania, 2010) . The major conclusions from these studies were that (1) neurotrophic factors are present in muscles innervated by MNs that do not depend on these factors for survival; and (2) neurotrophic receptors are expressed in motor pools that do not depend on their corresponding ligands for their survival. One striking example is provided by Ret and GDNF, which are broadly expressed in MNs and muscles, respectively. Despite this, gdnf-deficient mice show a loss of only ϳ25% MNs (Moore et al., 1996; Oppenheim et al., 2000) . Our data provide another illustration of this phenomenon: HGF is expressed in nearly all muscles [data not shown and Gu and Kania (2010) ], and Met is expressed in several subsets of MNs, and yet only one brachial pool depends on Met for survival. Thus, expression of a given trophic ligand/receptor couple is necessary but not sufficient to determine populations in which the factor regulates survival.
An alternative explanation for the specificity of our observations could be that survival of other pools is ensured by a mixture of factors with redundant functions. For example, although Met is expressed by the cutaneous maximus and the latissimus dorsi pools and regulates key developmental processes in these neurons, it becomes dispensable for their survival later on. This finding suggests that other factors are required to sustain survival of this population. One possibility is that these pools are dependent on another trophic factor such as GDNF, which plays multiple roles in their development (Henderson et al., 1994; Springer et al., 1995; Haase et al., 2002; Gould et al., 2008; Shneider et al., 2009 ). However, current evidence suggests that GDNF exerts its survival activity principally on gamma MNs, making this hypothesis less probable. Moreover, lack of pea3 induction in gdnf mutants precludes investigating directly whether GDNF supports the survival of the Pea3-positive MN pool. Another possibility is that HGF and GDNF exert redundant neurotrophic roles for the cutaneous maximus and the latissimus dorsi MN pools, thus reciprocally compensating for the loss of one another in single mutants.
Pleiotropic activities of HGF/Met: switching biological outcomes as a function of cell subtypes and time Another alternative explanation for the pool specificity of HGF survival effects could be that Met signaling is modulated by the genetic context of the cell in which it is expressed and that only in pectoralis minor MNs it activates a survival pathway. In agreement with this, we previously illustrated the concept of pleiotropic use of an RTK system by showing that HGF/Met acts on selective signaling pathways to trigger qualitatively distinct biological outcomes in different tissues (Maina et al., 2001) . Perhaps because of the need to strictly control its intrinsically pleiotropic properties, the HGF/Met biological response is imposed by the cell types in which it acts. For example, during embryogenesis, Met regulates survival in liver cells, whereas it is required for Figure 11 . pea3-positive MNs innervate the pectoralis minor muscle. Fluorescence imaging of the pectoralis minor muscle of E17.5 Etv4-EGFP transgenic mice. Double immunostaining of the pectoralis minor was performed using anti-NF (red) and anti-EGFP (green) antibodies, and is shown with merged colours (1), or separate channels (2, anti-NF-red; 3 anti-GFP, green). A, Observation of the entire muscle at low magnification shows that an EGFP signal is mostly seen in tendons (white arrowhead) and muscle spindles (white arrow). B, C, High magnification of the boxed areas in A and B, respectively, showing colocalization of EGFP and NF in axons (green) of Pea3-MNs.
proliferation and migration in muscle cells (Maina et al., 1996) . We now provide another level of specificity for pleiotropic RTK functions. We show that, among Met-expressing MNs, Met is not required for the survival of subsets (cutaneous maximus and latissimus dorsi MNs), in which it triggers axon growth/guidance and transcriptional responses (runx1 expression). However, it is necessary as a survival factor for the pectoralis minor MNs, in which it is dispensable for branching of this pectoral nerve (Fig. 14) . This selective HGF/Met requirement within the same cell type ( pea3-positive MNs) provides the most striking in vivo evidence so far that distinct subgroups of cells can make differential use of a pleiotropic factor for specific biological responses, such as identity acquisition, axonal growth, and survival.
Another aspect of our data implies a temporal control of neurotrophic signaling that may be important for a full understanding of the role of cell death and survival factors in shaping adult neuronal populations. The effects of HGF/Met on cell survival we report here occur after the well studied wave of NOCD at this level of the spinal cord (Yamamoto and Henderson, 1999) . This suggests that HGF is required for the continued maintenance of those MNs in the pectoralis minor pool that have survived the initial wave of NOCD. This switch in function according to the developmental stage that we report here is reminiscent of our studies on dorsal root ganglion sensory neurons. Whereas at E12.5, Met regulates survival of a subpopulation of sensory neurons expressing the TrkA receptor (Maina et al., 1997) , this trophic dependency is lost at later stages (Gascon et al., 2010) . Instead, after birth, HGF/Met acts synergistically with nerve growth factor (NGF)/ TrkA to promote expression of the peptidergic characteristics of a subset of nociceptive neurons (Gascon et al., 2010) , through crossrepressive regulatory interactions with Runx1, in contrast to the positive regulation we report in MNs. Other neurotrophic factors may also contribute to maintenance of MN numbers after the period of naturally occurring cell death (Baudet et al., 2008; Lee et al., 2008) . However, the degree to which these effects are pool specific was not determined.
Overall, our results provide novel insights into the role of neurotrophic factors in ensuring that subsets of MNs with specific adult functions are maintained throughout life. They suggest that the considerable degree of molecular diversity observed between MNs in different pools may not only serve for correct projections and circuit formation during early embryogenesis, but could potentially be required for appropriate pool-specific modulation of the outcome of signaling by Met and other RTK receptors. It was already known that some factors such as GDNF play pool-specific roles in MN positioning, axon growth, and circuit formation. Our data raise the possibility that different neurotrophic factors are also required for the survival of different groups of MNs. This provides a way in which the elegantly simple neurotrophic hypothesis first put forward for MNs by Levi-Montalcini (1987) may be modified to encompass our growing understanding of the functional and molecular diversity of spinal MNs.
